ThermoGenesis Holdings Inc (THMO):企業の財務・戦略的SWOT分析

◆英語タイトル:ThermoGenesis Holdings Inc (THMO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME460FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ThermoGenesis Holdings Inc (THMO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ThermoGenesis Holdings Inc (ThermoGenesis), formerly Cesca Therapeutics Inc, researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its offers AutoXpress platform for automated clinical biobanking. The company is also developing CAR-TXpress platform for bio-manufacturing which find applications in immuno-oncology therapeutics. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics, medical/diagnostic device development and commercialization, and cell manufacturing and banking. ThermoGenesis is headquartered in Rancho Cordova, California, the US.

ThermoGenesis Holdings Inc Key Recent Developments

Mar 17,2021: ThermoGenesis holdings announces 2020 year end financial results and provides corporate update
Mar 10,2021: ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2020 and Provide a Corporate Strategic Update
Feb 17,2021: ThermoGenesis Holdings begins a year of celebration of its 35th anniversary in the cell banking and cell therapy industry
Dec 18,2020: ThermoGenesis Holdings: Management update
Nov 12,2020: ThermoGenesis Holdings announces financial results for the third quarter ended September 30, 2020 and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ThermoGenesis Holdings Inc – Key Facts
ThermoGenesis Holdings Inc – Key Employees
ThermoGenesis Holdings Inc – Key Employee Biographies
ThermoGenesis Holdings Inc – Major Products and Services
ThermoGenesis Holdings Inc – History
ThermoGenesis Holdings Inc – Company Statement
ThermoGenesis Holdings Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
ThermoGenesis Holdings Inc – Business Description
Product Category: Device Revenue
Performance
Product Category: Other
Performance
Product Category: Service Revenue
Performance
Product Category: China
Performance
Product Category: Clinical Development
Overview
Performance
Product Category: Device
Overview
Performance
Key Stats
Geographical Segment: Asia – other
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
ThermoGenesis Holdings Inc – Corporate Strategy
ThermoGenesis Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
ThermoGenesis Holdings Inc – Strengths
ThermoGenesis Holdings Inc – Weaknesses
ThermoGenesis Holdings Inc – Opportunities
ThermoGenesis Holdings Inc – Threats
ThermoGenesis Holdings Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ThermoGenesis Holdings Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
ThermoGenesis Holdings Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
ThermoGenesis Holdings Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 17, 2021: ThermoGenesis holdings announces 2020 year end financial results and provides corporate update
Mar 10, 2021: ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2020 and Provide a Corporate Strategic Update
Feb 17, 2021: ThermoGenesis Holdings begins a year of celebration of its 35th anniversary in the cell banking and cell therapy industry
Dec 18, 2020: ThermoGenesis Holdings: Management update
Nov 12, 2020: ThermoGenesis Holdings announces financial results for the third quarter ended September 30, 2020 and provides corporate update
Aug 14, 2020: ThermoGenesis Holdings announces financial results for the second quarter ended June 30, 2020 and provides corporate update
May 14, 2020: ThermoGenesis announces financial results for first quarter ended March 31, 2020 and provides corporate update
Apr 21, 2020: ThermoGenesis Holdings receives loan under Paycheck Protection Program
Mar 24, 2020: ThermoGenesis Holdings announces 2019 year end financial results and provides corporate update
Jan 02, 2020: ThermoGenesis Holdings announces board of directors and management changes
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ThermoGenesis Holdings Inc, Key Facts
ThermoGenesis Holdings Inc, Key Employees
ThermoGenesis Holdings Inc, Key Employee Biographies
ThermoGenesis Holdings Inc, Major Products and Services
ThermoGenesis Holdings Inc, History
ThermoGenesis Holdings Inc, Other Locations
ThermoGenesis Holdings Inc, Subsidiaries
ThermoGenesis Holdings Inc, Joint Venture
ThermoGenesis Holdings Inc, Key Competitors
ThermoGenesis Holdings Inc, Ratios based on current share price
ThermoGenesis Holdings Inc, Annual Ratios
ThermoGenesis Holdings Inc, Annual Ratios (Cont...1)
ThermoGenesis Holdings Inc, Interim Ratios
ThermoGenesis Holdings Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
ThermoGenesis Holdings Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
ThermoGenesis Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ThermoGenesis Holdings Inc (THMO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eesti Energia AS:戦略・SWOT・企業財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Principia Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase inhibitor. It …
  • BELECTRIC GmbH:電力:M&Aディール及び事業提携情報
    Summary Belectric GmbH (Belectric) is a renewable energy company that offers solar systems and solutions. The company manufactures, designs, and constructs photovoltaic rooftop installation systems for solar-projects and ground-mounted solar power plants. It manufactures BoS components, photovoltaic …
  • Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive inform …
  • FlightSafety International Inc:企業の戦略・SWOT・財務情報
    FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report Summary FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Juniper Pharmaceuticals Inc (JNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a women’s health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in women's health. The company uti …
  • Orsted AS (DENERG)-エネルギー分野:企業M&A・提携分析
    Summary Orsted AS (Orsted) formerly Dong Energy A/S is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conventional fuel and wind energy sources. The company also develops, constructs, owns and o …
  • PDL BioPharma Inc (PDLI)-製薬・医療分野:企業M&A・提携分析
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • Arsenal Holdings plc:企業の戦略的SWOT分析
    Arsenal Holdings plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Massachusetts General Hospital-医療機器分野:企業M&A・提携分析
    Summary Massachusetts General Hospital (MGH) is a healthcare service provider which offers diagnostic and therapeutic care services. The hospital provides services such as allergy and immunology; ALS multidisciplinary clinic, anesthesia, critical care and pain medicine; back bay healthcare center, b …
  • The Jean Coutu Group (PJC) Inc.:企業の戦略・SWOT・財務分析
    The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report Summary The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cell Therapy Catapult Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cell Therapy Catapult Ltd (Catapult) is a provider of cell and gene therapy life cycle solutions. The company offers services such as industrialization, manufacturing, regulatory, health economics and market access, non-clinical safety and clinical operations. Its health economics and market …
  • OSE Immunotherapeutics (OSE):企業の財務・戦略的SWOT分析
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA, is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • Clark Construction Group, LLC:企業の戦略的SWOT分析
    Clark Construction Group, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Integrated BioPharma Inc (INBP):企業の財務・戦略的SWOT分析
    Summary Integrated BioPharma Inc (IBI) is a biopharmaceutical company that develops, manufactures and distributes vitamins, nutritional supplements and herbal products. The company’s contract business includes manufacturing, branded proprietary products, and other nutraceutical businesses. Its contr …
  • Net Insight AB (NETI B):企業の財務・戦略的SWOT分析
    Net Insight AB (NETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • ImevaX GmbH-製薬・医療分野:企業M&A・提携分析
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops specific vaccines against chronic infections. The company identifies and uses immune modulatory bacterial factors to develop specific vaccines. It develops specific vaccines against pathogens that cause chronic infectious dise …
  • Akorn Inc (AKRX)-製薬・医療分野:企業M&A・提携分析
    Summary Akorn Inc (Akorn) is a pharmaceutical company which carries out the development, manufacturing and commercialization of generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its product …
  • Trader Joe’s Company:企業の戦略・SWOT・財務情報
    Trader Joe's Company - Strategy, SWOT and Corporate Finance Report Summary Trader Joe's Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Touchstone Innovations plc (IVO):企業の財務・戦略的SWOT分析
    Summary Touchstone Innovations Plc (Touchstone Innovations), formerly Imperial Innovations Group Plc, a subsidiary of IP Group Plc, is a technology commercialization and investment company. The company creates, builds, and invests in early-stage pioneering technology companies and licensing opportun …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆